 SAN FRANCISCO, Jan. 04, 2022 GLOBE NEWSWIRE -- Vir Biotechnology, Inc. Nasdaq: VIR today announced that George Scangos, Ph.D., chief executive officer, will present at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, at 1:30 p.m. ET. 